Literature DB >> 23624998

Heart rate before ICU discharge: a simple and readily available predictor of short- and long-term mortality from critical illness.

Wilhelm Grander1, Kathrin Müllauer, Bernhard Koller, Herbert Tilg, Martin Dünser.   

Abstract

PURPOSE: A heart rate >90 bpm serves as one of four characteristics defining the systemic inflammatory response syndrome and is used in scoring systems to predict in-hospital mortality of intensive care unit (ICU) patients. Despite its central role in critical illness, specific data regarding the relationship between heart rate and outcome are rare.
METHODS: In this post hoc analysis of a prospectively collected database, we analyzed the value of heart rate averaged from four predefined time points during the last 24 h before ICU discharge as a predictor of post-ICU in-hospital and post-hospital mortality in medical ICU patients. Furthermore, the relationship between heart rate and inflammation, as well as the influence of rate control medications on the association between heart rate and outcome were identified.
RESULTS: Among the 702 ICU patients discharged from the ICU, 7.1 % died before hospital discharge. At 4 years of follow-up, post-hospital mortality was 14.4 %. Multivariate Cox proportional hazards models revealed heart rate before ICU discharge (HR 5.95; 95 % CI 1.24-28.63; p = 0.03) as an independent predictor of post-ICU in-hospital mortality. Both heart rate (HR 2.56; 95 % CI, 1.05-6.34; p = 0.04) and the C-reactive protein serum concentration before ICU discharge (HR, 1.26; 95 % CI, 1.09-1.46; p = 0.002) were independently associated with post-hospital mortality. Heart rate control therapy reduced the risk of post-ICU in-hospital (HR 0.38; 95 % CI, 0.18-0.81; p = 0.01) and post-hospital (HR, 0.47; 95 % CI, 0.22-1.00; p = 0.05) mortality.
CONCLUSION: Heart rate evaluated 24 h before ICU discharge was independently associated with post-ICU in-hospital and post-hospital mortality. Pharmacological interventions to control heart rate may beneficially influence post-ICU mortality.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23624998     DOI: 10.1007/s00392-013-0571-4

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN: 1861-0684            Impact factor:   5.460


  29 in total

1.  Reducing elevated heart rate in patients with multiple organ dysfunction syndrome by the I (f) (funny channel current) inhibitor ivabradine : MODI (f)Y trial.

Authors:  Sebastian Nuding; Henning Ebelt; Robert S Hoke; Annette Krummenerl; Andreas Wienke; Ursula Müller-Werdan; Karl Werdan
Journal:  Clin Res Cardiol       Date:  2011-06-03       Impact factor: 5.460

2.  Predictive value of resting heart rate for cardiovascular and all-cause mortality.

Authors:  Jaqueline Eilert Fagundes; Iran Castro
Journal:  Arq Bras Cardiol       Date:  2010-11-12       Impact factor: 2.000

3.  The association of resting heart rate with cardiovascular, cancer and all-cause mortality. Eight year follow-up of 3527 male Israeli employees (the CORDIS Study)

Authors:  E Kristal-Boneh; H Silber; G Harari; P Froom
Journal:  Eur Heart J       Date:  2000-01       Impact factor: 29.983

4.  Prognostic value of ambulatory heart rate revisited in 6928 subjects from 6 populations.

Authors:  Tine W Hansen; Lutgarde Thijs; José Boggia; Yan Li; Masahiro Kikuya; Kristina Björklund-Bodegård; Tom Richart; Takayoshi Ohkubo; Jørgen Jeppesen; Christian Torp-Pedersen; Lars Lind; Edgardo Sandoya; Yutaka Imai; Jiguang Wang; Hans Ibsen; Eoin O'Brien; Jan A Staessen
Journal:  Hypertension       Date:  2008-06-23       Impact factor: 10.190

Review 5.  Rest heart rate and life expectancy.

Authors:  H J Levine
Journal:  J Am Coll Cardiol       Date:  1997-10       Impact factor: 24.094

6.  Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease.

Authors:  Ariel Diaz; Martial G Bourassa; Marie-Claude Guertin; Jean-Claude Tardif
Journal:  Eur Heart J       Date:  2005-03-17       Impact factor: 29.983

7.  Controlling inflammation: the cholinergic anti-inflammatory pathway.

Authors:  V A Pavlov; K J Tracey
Journal:  Biochem Soc Trans       Date:  2006-12       Impact factor: 5.407

Review 8.  Clinical review: a review and analysis of heart rate variability and the diagnosis and prognosis of infection.

Authors:  Saif Ahmad; Anjali Tejuja; Kimberley D Newman; Ryan Zarychanski; Andrew Je Seely
Journal:  Crit Care       Date:  2009-11-24       Impact factor: 9.097

9.  Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial.

Authors:  Kim Fox; Ian Ford; P Gabriel Steg; Michal Tendera; Roberto Ferrari
Journal:  Lancet       Date:  2008-08-29       Impact factor: 79.321

Review 10.  Reflex control of immunity.

Authors:  Kevin J Tracey
Journal:  Nat Rev Immunol       Date:  2009-06       Impact factor: 53.106

View more
  6 in total

1.  [Predicting prolonged length of intensive care unit stay via machine learning].

Authors:  J Y Wu; Y Lin; K Lin; Y H Hu; G L Kong
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2021-12-18

2.  Serum procalcitonin level and SOFA score at discharge from the intensive care unit predict post-intensive care unit mortality: a prospective study.

Authors:  Yosuke Matsumura; Taka-aki Nakada; Ryuzo Abe; Taku Oshima; Shigeto Oda
Journal:  PLoS One       Date:  2014-12-02       Impact factor: 3.240

3.  Association between circadian variation of heart rate and mortality among critically ill patients: a retrospective cohort study.

Authors:  Jingjing Zhang; Linyun Du; Jiamei Li; Ruohan Li; Xuting Jin; Jiajia Ren; Ya Gao; Xiaochuang Wang
Journal:  BMC Anesthesiol       Date:  2022-02-12       Impact factor: 2.217

4.  Beta-blocker treatment in the critically ill: a systematic review and meta-analysis.

Authors:  Maria Heliste; Ville Pettilä; David Berger; Stephan M Jakob; Erika Wilkman
Journal:  Ann Med       Date:  2022-12       Impact factor: 5.348

5.  Post-ICU discharge and outcome: rationale and methods of the The French and euRopean Outcome reGistry in Intensive Care Units (FROG-ICU) observational study.

Authors:  Alexandre Mebazaa; Maria Chiara Casadio; Elie Azoulay; Bertrand Guidet; Samir Jaber; Bruno Levy; Didier Payen; Eric Vicaut; Matthieu Resche-Rigon; Etienne Gayat
Journal:  BMC Anesthesiol       Date:  2015-10-12       Impact factor: 2.217

6.  Landiolol in patients with septic shock resident in an intensive care unit (LANDI-SEP): study protocol for a randomized controlled trial.

Authors:  Martin Unger; Andrea Morelli; Mervyn Singer; Peter Radermacher; Sebastian Rehberg; Helmut Trimmel; Michael Joannidis; Gottfried Heinz; Vladimír Cerny; Pavel Dostál; Christian Siebers; Fabio Guarracino; Francesca Pratesi; Gianni Biancofiore; Massimo Girardis; Pavla Kadlecova; Olivier Bouvet; Michael Zörer; Barbara Grohmann-Izay; Kurt Krejcy; Christoph Klade; Günther Krumpl
Journal:  Trials       Date:  2018-11-19       Impact factor: 2.279

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.